Suchergebnisse - "Berdeja, Jesús G"

PubPharm (100)

1

Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma

enthalten in: British journal of haematology | 2023

von Mohan, M. | Chakraborty, R. | Bal, S. | +7

2

Multiple myeloma : a paradigm for blending community and academic care

enthalten in: Hematology. American Society of Hematology. Education Program | 2023

von Berdeja, J.

3

Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Htut, M. | Dhakal, B. | Cohen, A. | +13

4

Idecabtagene vicleucel for relapsed and refractory multiple myeloma : post hoc 18-month follow-up of a phase 1 trial

enthalten in: Nature medicine | 2023

von Lin, Y. | Raje, N. | Berdeja, J. | +19

5

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

enthalten in: The New England journal of medicine | 2023

von Richardson, P. | Trudel, S. | Popat, R. | +60

6

Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel

enthalten in: Blood cancer discovery | 2023

von Paiva, B. | Manrique, I. | Rytlewski, J. | +12

CommentIn: Blood Cancer Discov. 2023 Sep 1;4(5):346-348. - PMID 37655402

7

Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice

enthalten in: Haematologica | 2023

von Mateos, M. | Weisel, K. | Martin, T. | +20

CommentIn: Haematologica. 2023 Aug 01;108(8):1988-1990. - PMID 37021536

8

SOHO State-of-the-Art Updates and Next Questions | BCMA-Directed CAR T-Cells : Early Results and Future Directions

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Biltibo, E. | Berdeja, J.

9

Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Thompson, M. | Boccadoro, M. | Leleu, X. | +26

10

Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma : CARTITUDE-1 2-Year Follow-Up

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Martin, T. | Usmani, S. | Berdeja, J. | +25

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]